KMT2A and acute myeloid leukemia: The presented study elucidated the specific cell killing of HU in MLL-r AML cell lines through an alternative mechanism, targeting matrix metallopeptidase 2 (MMP2), where inhibition of ribonucleotide reductase regulatory subunit M2 (RRM2) was not the primary factor.